Blog
RSS FeedPosted by Michael Wonder on 23 Jan 2020
Want to know how contentious drug pricing is in Washington? Check the receipts.
23 January 2020 - Pfizer, Johnson & Johnson, Merck, and the 31 other major drug makers that belong to the ...
Posted by Michael Wonder on 23 Jan 2020
Sick of high drug prices, insurers join hospitals to make their own generic medications
23 January 2020 - Everyone complains about high drug prices. But hospitals — and now insurers — are trying to ...
Posted by Michael Wonder on 22 Jan 2020
Competition, not capping increases, is the cure for high drug prices
22 January 2020 - Soaring prescription drug prices are putting financial pressure on families across the country. ...
Posted by Michael Wonder on 21 Jan 2020
Pharma says price regulation will take life saving drugs away from us, but here’s the truth
21 January 2020 - The US isn’t the only country struggling with the high price of prescription drugs. A decade ...
Posted by Michael Wonder on 20 Jan 2020
Talkin’ about a resolution: issues in the push for greater transparency of medicine prices
20 January 2020 - At the 2019 World Health Assembly, a significant new resolution was agreed by most countries to start ...
Posted by Michael Wonder on 20 Jan 2020
Patients still struggle to balance high costs of MS treatment, despite generic
20 January 2020 - Sometimes, the approval of a new generic drug offers more hype than hope for patients' wallets, ...
Posted by Michael Wonder on 19 Jan 2020
China drives down drug prices with bulk buy bidding
18 January 2020 - Pharma giants that used to profit from off-patent drugs forced to compete with local generic makers. ...
Posted by Michael Wonder on 17 Jan 2020
Airing frustrations with pharma, a Republican FTC commissioner just endorsed Medicare negotiation
16 January 2020 - A Republican member of the Federal Trade Commission on Thursday expressed support for allowing Medicare to ...
Posted by Michael Wonder on 17 Jan 2020
Pricing of pharmaceuticals is becoming a major challenge for health systems
13 January 2020 - Manufacturers using their market power to maximise profits results in prices that are unjustifiable and unaffordable. ...
Posted by Michael Wonder on 17 Jan 2020
Defining the concept of fair pricing for medicines
13 January 2020 - Suerie Moon and colleagues consider what makes a fair price for both buyers and sellers. ...
Posted by Michael Wonder on 17 Jan 2020
BioMarin explores pricing experimental gene therapy at $2 million to $3 million
16 January 2020 - Valrox would be first gene therapy approved in U.S. for inherited type of haemophilia. ...
Posted by Michael Wonder on 16 Jan 2020
EQRX wants to make high-end medicines less costly
17 January 2020 - A Boston-based biotech startup thinks it has found a lucrative third way between high-margin branded drugs and ...
Posted by Michael Wonder on 16 Jan 2020
Pharma execs pitch ideas at JPM20 to lower drug costs. None of them include dropping their own prices.
16 January 2020 - CEOs from the world’s largest pharmaceutical companies pitched ideas for lowering drug prices at the J.P. Morgan ...
Posted by Michael Wonder on 16 Jan 2020
U.S. targets drug pricing, no-poach deals for anti-trust action in 2020
15 January 2020 - Justice Department antitrust chief also promises decision on music licensing, criticizes states’ lawsuit against T-Mobile and Sprint. ...
Posted by Michael Wonder on 16 Jan 2020
Prices of MS medications keep soaring
15 January 2020 - The cost of essential medications for multiple sclerosis have nearly tripled this decade, despite the release ...